Clinical Trial Update: OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

View source ↗

Summary

This clinical trial update describes compassionate-use access to OMS721 (Narsoplimab) for patients with thrombotic microangiopathy under study NCT02355782.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Microangiopathy

Drugs mentioned

• OMS721 (narsoplimab)

Snippet

Sponsor: Michal Nowicki | Conditions: Thrombotic Microangiopathy | Status: AVAILABLE